首页> 美国卫生研究院文献>Archives of Medical Science : AMS >Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction
【2h】

Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction

机译:ST段抬高型心肌梗死经皮冠状动脉介入治疗入路选择随机试验的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionSuperior outcomes with transradial (TRPCI) versus transfemoral coronary intervention (TFPCI) in the setting of acute ST-segment elevation myocardial infarction (STEMI) have been suggested by earlier studies. However, this effect was not evident in randomized controlled trials (RCTs), suggesting a possible allocation bias in observational studies. Since important studies with heterogeneous results regarding mortality have been published recently, we aimed to perform an updated review and meta-analysis on the safety and efficacy of TRPCI compared to TFPCI in the setting of STEMI.
机译:简介较早的研究表明,在急性ST段抬高型心肌梗死(STEMI)的情况下,经radi动脉(TRPCI)与经股动脉冠状动脉介入治疗(TFPCI)相比具有更好的疗效。但是,这种效果在随机对照试验(RCT)中并不明显,这表明观察性研究可能存在分配偏差。由于最近发表了有关死亡率的异质性结果的重要研究,因此我们旨在就STEMI的背景下与TFPCI相比,对TRPCI的安全性和有效性进行更新的回顾和荟萃分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号